
Angioplasty balloon maker r4 Technologies wins FDA approval
Maple Grove, Minn.-based r4 Technologies landed FDA approval for its Vector percutaneous transluminal angioplasty balloon catheters, which come in 28 different sizes.
The devices help keep access sites open for dialysis treatments, which restore blood flow in the legs, or to dilate narrowings in the renal arteries or in other vessels throughout the body.
Read more
Wilmington, N.C.-based TranS1 (NSDQ:TSON) won CE Mark approval in the European Union for its Veo lateral access fusion system, which features a 2-stage retraction method designed for direct visualization of the muscles and nerves prior to muscle dissection.
Read more
Flagstaff, Ariz.-based W.L. Gore & Associates won CE Mark for new sizes of its Gore Excluder AAA endoprosthesis for treatment of abdominal aortic aneurysms.
Read more